Cataract Surgery in Patients With Corneal Disease

In the “Cataract Surgery in Patients with Corneal Disease” session at the 2025 ASCRS meeting, Zeba A. Syed, MD, provided an overview of several corneal diseases and what physicians need to know when it comes to treating cataract patients.

By
Julie Greenbaum, editor
April 1, 2025
4 min

Ophthalmology Management

Overview

Dr. Zeba A. Syed highlights key considerations for cataract surgery in patients with corneal disease, emphasizing the impact of corneal conditions on intraocular lens (IOL) selection, surgical outcomes, and disease progression. Proper preoperative management of ocular surface disease and corneal dystrophies is critical for optimal visual results.

Background

Corneal diseases can complicate cataract surgery by affecting accurate IOL calculations, potentially worsening preexisting corneal conditions, and limiting postoperative visual outcomes. Conditions such as dry eye, anterior basement membrane dystrophy (ABMD), herpes simplex keratitis, keratoconus, and Fuchs endothelial corneal dystrophy require careful evaluation and management before surgery. Understanding these factors is essential for selecting appropriate surgical techniques and IOLs to maximize patient outcomes.

Data Highlights

Key timing recommendations include waiting at least 3 months after treating ABMD before performing biometry and ensuring herpes simplex keratitis is inactive for at least 3 months prior to surgery. Toric IOLs are suitable only for patients with stable keratoconus and regular astigmatism components. In mild Fuchs dystrophy, cataract surgery alone may be performed with modifications to reduce endothelial damage.

Key Findings

Significant dry eye affects corneal topography and keratometry, necessitating ocular surface treatment before biometry for accurate IOL selection.
ABMD should be treated if symptomatic, if premium IOLs are planned, or if irregular astigmatism involves the central cornea; topography should be obtained preoperatively.
Herpes simplex keratitis must be inactive for at least 3 months before cataract surgery, with antiviral prophylaxis recommended to reduce recurrence risk.
Keratoconus patients develop visually significant cataracts earlier; stable disease is required before surgery, and toric IOLs only correct regular astigmatism components.
Fuchs endothelial corneal dystrophy often coexists with cataracts; mild cases may undergo cataract surgery alone with techniques minimizing endothelial trauma.
Combined procedures involving corneal grafts and cataract surgery carry risks including graft adherence issues and increased rejection, requiring careful surgical planning.

Clinical Implications

Clinicians should thoroughly evaluate and manage corneal surface disease and dystrophies prior to cataract surgery to ensure accurate IOL calculations and reduce postoperative complications. Selecting appropriate IOL types, such as avoiding toric lenses in irregular astigmatism, and timing surgery to allow disease stabilization are essential for optimizing visual outcomes. Special surgical techniques to protect the corneal endothelium are recommended in patients with Fuchs dystrophy.

Conclusion

Effective cataract surgery in patients with corneal disease requires individualized assessment and management of corneal conditions to optimize IOL selection and surgical outcomes. Preoperative stabilization and tailored surgical approaches can mitigate risks and improve visual prognosis.